BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, Q2 2026
5,098
Period ended Jun 30, 2026
Change on a year earlier
+85.0%
2,756 in Q2 2025
History
48 quarters
Since Q4 2013
Sources
38
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash and cash equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,098 | +85.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,792 | +90.4% | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 4,548 | +72.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,037 | +49.4% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,756 | +6.3% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,516 | -9.9% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,639 | -16.8% | Form 10-Q (filed 2026-05-06) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,702 | -11.9% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,593 | -24.0% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,793 | -21.1% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,172 | -18.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,067 | -26.9% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,410 | -24.7% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 3,539 | -18.6% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 3,875 | -11.6% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2022 | Sep 30, 2022 | 4,197 | +203.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,531 | +155.1% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 4,347 | +128.6% | Form 10-Q (filed 2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 4,383 | +215.3% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,383 | -5.5% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,776 | +32.1% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,902 | -2.8% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,390 | +123.9% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,465 | +70.9% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,345 | +46.4% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,957 | +156.0% | Form 10-Q (filed 2020-05-11) ↗ |
| Q4 2019 | Dec 31, 2019 | 621 | -16.2% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2019 | Sep 30, 2019 | 857 | +33.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 919 | +109.6% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 765 | +55.8% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 741 | +209.1% | Form 10-K (filed 2022-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | 644 | +208.6% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 438 | +68.0% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 491 | +401.6% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 240 | +173.8% | Form 10-K (filed 2018-02-28) ↗ |
| Q3 2017 | Sep 30, 2017 | 209 | +143.9% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 261 | +349.2% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | 97.8 | -53.1% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 87.5 | +388.8% | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2016 | Sep 30, 2016 | 85.5 | +212.0% | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | 58.1 | +130.6% | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | 209 | +1,456.0% | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2015 | Dec 31, 2015 | 17.9 | +28.8% | Form 10-Q (filed 2016-05-12) ↗ |
| Q3 2015 | Sep 30, 2015 | 27.4 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2015 | Jun 30, 2015 | 25.2 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2015 | Mar 31, 2015 | 13.4 | – | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2014 | Dec 31, 2014 | 13.9 | +256.4% | Form 10-K (filed 2018-02-28) ↗ |
| Q4 2013 | Dec 31, 2013 | 3.90 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Cash and cash equivalents ($M) ($M), quarterly Q4 2013–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_cash
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.